Komori
Vital Ksk Holdings (3151) · InitiativeRestated

Developing New Revenue Initiatives and Businesses by Leveraging Strengths and Resources

First written in FY2019. 12 of 14 entries say "Restated". Latest entry: FY2026.

14entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2022AdvancedFY20252019: 320192020: 420202021: 320212022: 220222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies
Diversifying Revenue Sources Through New BusinessesA theme 163 companies write about · 0 as a headwind · 168 as a tailwind

28 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 163 companies compared. The sentences above are computed from all 163.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「• Generate new revenue by strengthening digital marketing / • Focus on distinctive pharmaceutical distribution in areas including oncology, vaccines, women’s healthcare and regional collaboration」

    The Company has reaffirmed its focus areas for generating new revenue and distinctive pharmaceutical distribution.
  2. FY2025AdvancedAnnual report

    「• Generate new revenue by strengthening digital marketing / • Focus on distinctive pharmaceutical distribution in areas including oncology, vaccines, women’s healthcare and regional collaboration」

    For new revenue initiatives leveraging its strengths and resources, the Company identifies digital marketing, oncology, vaccines, women’s healthcare and regional collaboration as specific focus areas.
  3. FY2022RestatedAnnual report

    「In addition to promotional activities using DX suited to the new normal, the Company is actively pursuing the expansion of new businesses, including undertaking distribution operations for specialty pharmaceuticals in response to changes in drug discovery modalities.」

    As new revenue initiatives and business developments leveraging its existing strengths and resources, the Company continues its DX promotion activities and contract distribution services for specialty pharmaceuticals.
  4. FY2022-Q3RestatedAnnual report

    「The Company will continue to pursue the four basic policies: “Realizing the full strength of the Group through effective and efficient group management,” “Expanding and strengthening the functions provided and focusing on growth areas,” “Coordinating and supporting local healthcare and providing solutions,” and “Developing new revenue measures and businesses by leveraging its strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its strengths and resources in the final year of the Fourth Medium-Term Management Plan.
  5. FY2022-Q2RestatedAnnual report

    「The Company will continue to pursue the four basic policies: “Realizing the full strength of the Group through effective and efficient group management,” “Expanding and strengthening the functions provided and focusing on growth areas,” “Coordinating and supporting local healthcare and providing solutions,” and “Developing new revenue measures and businesses by leveraging its strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its strengths and resources in the final year of the Fourth Medium-Term Management Plan.
  6. FY2022-Q1RestatedAnnual report

    「The Company will continue to pursue the four basic policies: “Realizing the full strength of the Group through effective and efficient group management,” “Expanding and strengthening the functions provided and focusing on growth areas,” “Coordinating and supporting local healthcare and providing solutions,” and “Developing new revenue measures and businesses by leveraging its strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its strengths and resources in the final year of the Fourth Medium-Term Management Plan.
  7. FY2021-Q3RestatedAnnual report

    「Furthermore, to realize this medium-term vision, the Company is pursuing the four basic policies: “Realizing the full strength of the Group through effective and efficient group management,” “Expanding and strengthening the functions provided and focusing on growth areas,” “Coordinating and supporting local healthcare and providing solutions,” and “Developing new revenue measures and businesses by leveraging its strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its strengths and resources as a basic policy.
  8. FY2021-Q2RestatedAnnual report

    「“We are working to develop new revenue initiatives and businesses by leveraging our strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its strengths and resources as a basic policy.
  9. FY2021-Q1RestatedAnnual report

    「“We are working to develop new revenue initiatives and businesses by leveraging our strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its existing strengths and resources as a basic policy.
  10. FY2020RestatedAnnual report

    「Developing New Revenue Initiatives and Businesses by Leveraging Strengths and Resources」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its existing strengths and resources as a basic policy.
  11. FY2020-Q3RestatedAnnual report

    「Furthermore, to realize this medium-term vision, the Company will pursue the four basic policies: “Realizing the full strength of the Group through effective and efficient group management,” “Expanding and strengthening the functions provided and focusing on growth areas,” “Coordinating and supporting local healthcare and providing solutions,” and “Developing new revenue measures and businesses by leveraging its strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its strengths and resources as a basic policy.
  12. FY2020-Q2RestatedAnnual report

    「Furthermore, to realize this medium-term vision, the Company will pursue the four basic policies: “Realizing the full strength of the Group through effective and efficient group management,” “Expanding and strengthening the functions provided and focusing on growth areas,” “Coordinating and supporting local healthcare and providing solutions,” and “Developing new revenue measures and businesses by leveraging its strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its strengths and resources as a basic policy.
  13. FY2020-Q1RestatedAnnual report

    「“We will work to develop new revenue initiatives and businesses by leveraging our strengths and resources.”」

    The Company continues to pursue the development of new revenue initiatives and businesses by leveraging its existing strengths and resources as a basic policy.
  14. FY2019First statedAnnual report

    「Developing New Revenue Initiatives and Businesses by Leveraging Strengths and Resources」

    The Company has set out a basic policy of developing new revenue initiatives and businesses by leveraging its existing strengths and resources.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Vital Ksk Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Developing New Revenue Initiatives and Businesses by Leveraging Strengths and Resources | VITAL KSK HOLDINGS,INC. (3151) | Komori